CYP2B6 polymorphisms and nevirapine and efavirenz DILI

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2024年 / 2037卷 / 1期
关键词：
D O I：
10.1007/s40278-024-71697-7
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4 / 4
相关论文
共 50 条
  • [41] Identification and functional significance of polymorphisms in the human CYP2B6 gene
    Lang, T
    Klein, K
    Fischer, J
    Eichelbaum, M
    Schwab, M
    Zanger, UM
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2001, 363 (04) : R126 - R126
  • [42] Single Heteroatom Substitutions in the Efavirenz Oxazinone Ring Impact Metabolism by CYP2B6
    Cox, Philip M.
    Bumpus, Namandj N.
    CHEMMEDCHEM, 2016, 11 (23) : 2630 - 2637
  • [43] CYP2B6*6 or Not CYP2B6*6-That Remains a Question for Precision Medicine and Ketamine!
    Cook-Sather, Scott D.
    Adamson, Peter C.
    Li, Jin
    Hakonarson, Hakon
    ANESTHESIOLOGY, 2016, 125 (06) : 1085 - 1087
  • [44] Prevalence of CYP2B6 polymorphisms in Argentinians: the role of genetic testing
    Scibona, P.
    Vazquez, C.
    Cajal, A. R.
    Argibay, P. F.
    Belloso, W. H.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (04): : 16594 - 16599
  • [45] Prenatal efavirenz exposure is independently associated with maternal, but not fetal CYP2B6 genotype
    Eniayewu, Oluwasegun
    Akinloye, Abdulafeez
    Shenkoya, Babajide
    Azuka, Uche
    Bolaji, Oluseye
    Adejuyigbe, Ebunoluwa
    Owen, Andrew
    Olagunju, Adeniyi
    PHARMACOGENETICS AND GENOMICS, 2024, 34 (08): : 253 - 260
  • [46] Effect of CYP2B6 genotype on the plasma efavirenz exposure in an African HIV woman
    Le Dauphin, Emmanuelle
    Barrail-Tran, Aurelie
    Brunet, Anne
    Bouligand, Jerome
    Goujard, Cecile
    Taburet, Anne-Marie
    PHARMACY WORLD & SCIENCE, 2009, 31 (02): : 331 - 332
  • [47] Would a CYP2B6 test help HIV patients being treated with efavirenz?
    Sukasem, Chonlaphat
    Sungkanuparph, Somnuek
    PHARMACOGENOMICS, 2013, 14 (09) : 999 - 1001
  • [48] Potent inhibition of efavirenz secondary metabolism by CYP2B6 inhibitors in vitro.
    Huh, W.
    Jones, D. R.
    Jeong, S.
    Flockhart, D. A.
    Desta, Z.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S43 - S44
  • [49] Genetic variants of CYP2B6 decrease rate of efavirenz metabolism in vitro.
    Desta, Z
    Ward, BA
    Flockhart, DA
    Richter, T
    Klein, K
    Zanger, UM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P24 - P24
  • [50] Frequency of CYP2B6 Alleles in Major Iranian Ethnicities, Affecting Response to Efavirenz
    Mardi, Parham
    Tavakoli-Far, Bahareh
    Nia, Samira Sheibani
    Jazayeri, Roshanak
    Houshmand, Massoud
    GENETICS RESEARCH, 2022, 2022
12345